
3x colon cancer survivor | #EOCRC | Author & Speaker | @GICancersAlliance COO
Kansas City Metro
Joined March 2009
- Tweets10.5K
- Following2.3K
- Followers2K
- Likes12.4K
Danielle Ripley-Burgess retweeted
Meet Margaret-AnnSimonetta, President of the Board of Directors for @gicalliance and host of "The Real Gastrochat Podcast," a new podcast presented by @oncodaily in partnership with GICA
Listen to the podcast: open.spotify.com/episode/6TO……
Read the article: oncodaily.com/dialogues/gast…
Releasing October 6 with @BroadStreetPubl! Available online anywhere books are sold! #devotional #faith #DailyDevotional
Danielle Ripley-Burgess retweeted
Who sets the cancer research agenda, and who gets left out?
🔬 Our CEO Martha Raymond will join the live panel "Who Sets the Research Agenda?" at #Immuno2026 from @oncodaily & @parkerici.
📅 Tue, Sept 29 · 1:40 PM ET
🔗 oncodaily.com/immuno-2026-gl…
#GICancer
Danielle Ripley-Burgess retweeted
A conversation about biomarker-driven therapies may lead to questions about access. If "compassionate use" or "expanded access" programs come up, here's what those terms mean. #testyourbiomarker #compassionateuse #cancer
So proud of our @GICAlliance CEO Martha Raymond for sharing what's driven her 40 years of advocacy in the latest issue of @CancerWorldmag! #covergirl
📣CancerWorld #118 (August 2026) is live!
❤️ 𝐖𝐡𝐨 𝐰𝐢𝐥𝐥 𝐰𝐫𝐢𝐭𝐞 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐜𝐡𝐚𝐩𝐭𝐞𝐫 𝐨𝐟 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲?
For generations, progress in cancer care has been driven by scientific discovery, technological innovation, and clinical excellence.
Today, another force is helping shape its future: 𝐥𝐢𝐯𝐞𝐝 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞.
The August issue of CancerWorld explores how patients, survivors, caregivers, and advocates are becoming partners in research, policy, education, and the delivery of cancer care.
Our two cover stories embody this transformation. 𝐌𝐚𝐫𝐭𝐡𝐚 𝐑𝐚𝐲𝐦𝐨𝐧𝐝, a pioneer in gastrointestinal cancer advocacy, reflects on more than four decades of advancing patient partnership in oncology. 𝐆𝐥𝐨𝐫𝐢𝐚 𝐎𝐤𝐰𝐮 shares how her own breast cancer diagnosis became the catalyst for one of Nigeria's leading patient advocacy movements.
Beyond our cover stories, this issue explores how lived experience is reshaping every dimension of oncology—from survivorship and mental health to patient-reported outcomes, AI-supported patient navigation, and the growing role of patients as partners in research, policy, and cancer care. Together, these stories remind us that the future of oncology will be shaped as much by human experience as by scientific discovery.
Because the future of oncology will be written not only by those who study cancer, but also by those who live with it.
📖 Read the August issue of CancerWorld here: lnkd.in/gFqdgUza
@oncodaily | @OncoDailyGI | @GICAlliance | @Andronika_1 | @tamikafelder | @iamcervivor | @CancerPatientsE | @EuropaDonnaEUR | @vickyyyf @DarrenHaywood14
Danielle Ripley-Burgess retweeted
Proud to stand in unity alongside the cancer advocacy community. Thank you for your leadership @ACSCAN!
Nearly 200 patient advocacy, public health & health care professional orgs, including ACS CAN, sent a letter to the Senate declaring support for the Clinical Trial Modernization Act, which would help reduce cost & geographic barriers to #ClinicalTrials. fightcancer.org/releases/nea…
Danielle Ripley-Burgess retweeted
We're excited to welcome Professor John Marshall from @QMBCI to our Medical Advisory Committee!
Danielle Ripley-Burgess retweeted
We Are Only Here to Help… Hear from Cancer Survivors
@MatthewZachary @TheQueenVee @CancerHopeNet @karenbythelee24 @MucosalMelanoma @sandyduarte @OliviaMannion_ @DanielleisB @paltown1 @GitteJoergensen @stacy_hurt
oncodaily.com/voices/cancer-…
Danielle Ripley-Burgess retweeted
We spy our COO @DanielleisB, a 25-year #colorectalcancer survivor!
100 Influential Cancer Survivors on Social Media: 2026 Edition
When you hear the words "you have cancer," what happens next defines everything.
A few decades ago, a cancer diagnosis often meant stepping back from life, from work, from public roles, from the future you had imagined. Treatment was gruelling, options were limited, and survivorship was rarely part of the conversation.
Today, more people than ever are not just surviving cancer, they are leading through it.
Researching it. Speaking about it. Changing policy because of it.
That shift happened one story, one voice, one act of courage at a time.
In 2026, OncoDaily recognises 100 influential cancer survivors who refused to let their diagnosis be the end of their story and in doing so, have helped rewrite the story for all of us.
oncodaily.com/100/100-most-i…
#CancerSurvivors #OncoDaily #Cancer #Oncology #BIGR #NationalCancerSurvivorsMonth
Not surprising... cancer as a kid is not easy! cancertherapyadvisor.com/new… Survivors of childhood cancer have a higher risk for antidepressant use #ayacancer @GICAlliance
Danielle Ripley-Burgess retweeted
Top trials to watch at ESMO GI 2026
• CAPRI-2 GOIM: cetuximab in molecularly selected mCRC
• KRYSTAL-10: adagrasib + cetuximab in 2L KRAS G12C mCRC
• ATOMIC: treatment duration in stage III dMMR colon cancer
• EMERALD-3: STRIDE ± lenvatinib + TACE in eeHCC
• EMERALD-1: final OS with durvalumab ± bevacizumab + TACE
• Futibatinib + zimberelimab + chemotherapy in 1L advanced BTC
• TRIPP-FFX: phosphorus-32 microparticles + FOLFIRINOX in uLAPC
• Zoldonrasib + daraxonrasib in 2L+ KRAS G12D mPDAC
• STAR-221: domvanalimab + zimberelimab + chemotherapy in HER2-negative GEA
• HERIZON-GEA-01: HRQoL with zanidatamab-based therapy in HER2+ mGEA
@susanmgalbraith @GABOUALFA @DrErinjeri @KoheiShitara @TaberneroJosep @NiallTebbutt @JafferAjaniMD @inales40 @FilippoPietran4 @chierrocarbo @FilipHerpe @DCiardiello @NicolaNormanno @cllotesoriere @ChiaraCrem1 @ArndtVogel @pashtoonkasi @SuyogCancer @ReinacherAnke
Read more on OncoDaily -> oncodaily.com/oncolibrary/ga…
#ESMOGI26 #GICancer #Oncology
Danielle Ripley-Burgess retweeted
Danielle Ripley-Burgess Unveils New Book Inspired by Lessons in Cancer Survivorship
@DanielleisB @DanSportsLife @nottlerack
oncodaily.com/voices/daniell…
Danielle Ripley-Burgess retweeted
This was an unforgettable #ASCO26 for us. Thank you to everyone who met with us, shared your research & voice, and paved a way for the future of cancer care! @TheQueenVee @DanielleisB
Danielle Ripley-Burgess retweeted
Our team is growing! Welcoming @danielleisb as COO. gicancersalliance.org/news/g…
It's a wonderful thing to get older as a cancer survivor, yet complex at the same time. I wrote about it this month for @cure_today curetoday.com/view/aging-out…
Danielle Ripley-Burgess retweeted
Want to better understand how biomarkers impact your #CRC diagnosis?
Enroll in our free Biomarker School and start learning today: community.fightcrc.org/share…
Thank you, @SiliconBio, for supporting this important education! 💙
Danielle Ripley-Burgess retweeted
Got a bold idea to change the future of hereditary or early-onset #CRC? We've partnered with @CGAIGC to offer a $15K grant for projects advancing science, care, or advocacy for inherited syndromes, familial CRC, or #EOCRC.
Learn more & apply today: cgaigc.com/grant-opportuniti…
Danielle Ripley-Burgess retweeted
Preparing for surgery? Don't forget the essentials.
Our FREE brochure for #colorectalcancer patients covers what to ask your doctor, side effects to expect, and more. Download or request a printed copy today.
Thanks to @IntuitiveSurg for supporting this resource!
Danielle Ripley-Burgess retweeted
It was a phenomenal first day of FightCRC's Global EOCRC Think Tank. 22+ countries joined to share ideas, build connections, & kick off a two-year commitment to confront this global crisis @IBSAL_IIS @bowelcanceruk @BowelCancerAust @josepereag @GlobalCRC @dice_europe @coloncanada






















